We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · August 19, 2020

The Association of Radiation Dose Fractionation and Immunotherapy With Overall Survival in Metastatic Melanoma

Cureus

 

Additional Info

Cureus
The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients
Cureus 2020 Jun 22;[EPub Ahead of Print], SJ Wang, SR Jhawar, Z Rivera-Nunez, AW Silk, J Byun, E Miller, D Blakaj, RR Parikh, J Weiner, S Goyal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading